JO
VOR icon

John Overdeck’s Vor Biopharma VOR Stock Holding History

John Overdeck’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$681K Buy
+37,012
New +$560K ﹤0.01% 3912
2025
Q3 		– Sell
-8,482
Closed -$275K – 3951
2025
Q2 		$275K Buy
8,482
+2,332
+38% +$20.6K ﹤0.01% 2822
2025
Q1 		$88.2K Sell
6,150
-2,003
-25% -$48.1K ﹤0.01% 2979
2024
Q4 		$181K Buy
8,153
+1,296
+19% +$21.5K ﹤0.01% 2890
2024
Q3 		$96K Buy
+6,857
New +$125K ﹤0.01% 2904
2023
Q3 		– Sell
-1,405
Closed -$86.8K – 3238
2023
Q2 		$86.8K Buy
1,405
+349
+33% +$31.9K ﹤0.01% 2771
2023
Q1 		$114K Sell
1,056
-1,664
-61% -$184K ﹤0.01% 2656
2022
Q4 		$362K Buy
2,720
+1,990
+273% +$197K ﹤0.01% 2168
2022
Q3 		$58K Buy
+730
New +$71.8K ﹤0.01% 2302

Other funds holding VOR

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

John Overdeck's VOR Position: Q2 2026 in Review

John Overdeck opened a new position in Vor Biopharma (VOR) in Q2 2026: 37,012 shares worth $681K. The stake represents ﹤0.01% of the portfolio and ranks #3912 among its holdings. This is a return to the name: John Overdeck previously reported a position in VOR as recently as Q2 2025.

John Overdeck first reported a position in VOR in Q3 2022 and has held it in 9 quarters since. 101 funds tracked by Wall St. Rank hold VOR as of Q2 2026.

  • John Overdeck held 37,012 shares of Vor Biopharma worth $681K as of Q2 2026.
  • Vor Biopharma was a new John Overdeck position in Q2 2026.
  • Vor Biopharma made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #3912 holding.
  • John Overdeck first reported a position in Vor Biopharma in Q3 2022 and has held it in 9 quarters since.
  • 101 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.